Journal Article

Novel Treatment of Meningitis Caused by Multidrug-Resistant <i>Mycobacterium tuberculosis</i> with Intrathecal Levofloxacin and Amikacin: Case Report

Shaun E. Berning, Teresa A. Cherry and Michael D. Iseman

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 32, issue 4, pages 643-646
Published in print February 2001 | ISSN: 1058-4838
Published online February 2001 | e-ISSN: 1537-6591 | DOI: https://dx.doi.org/10.1086/318698
Novel Treatment of Meningitis Caused by Multidrug-Resistant Mycobacterium tuberculosis with Intrathecal Levofloxacin and Amikacin: Case Report

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

We report the case of a 25-year-old HIV-negative man with disseminated multidrug-resistant tuberculosis (MDRTB), who—on a retreatment regimen—experienced total resolution of TB miliary disease, but progressive TB meningitis. Therefore, intrathecal treatment with amikacin and levofloxacin was instituted, with successful clinical and microbiological results.

Journal Article.  2128 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.